ABIGAIL BEHRENS: Open Payments
NPI 1003315201 · DENISON, IA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$477 in 30 payments from 8 companies in 2025. Trend: 2023 $723 · 2024 $569 · 2025 $477
Food & beverage: $392Education: $85
| Company | Payments | Amount |
|---|---|---|
| SUN PHARMACEUTICAL INDUSTRIES INC. | 17 | $254 |
| UCB, Inc. | 4 | $64 |
| ABBVIE INC. | 2 | $45 |
| Lilly USA, LLC | 2 | $35 |
| Galderma Laboratories, L.P. | 2 | $32 |
| Arcutis Biotherapeutics, Inc. | 1 | $23 |
| Regeneron Healthcare Solutions, Inc. | 1 | $19 |
| Organon LLC | 1 | $6 |
Products named: ILUMYA, Bimzelx, EBGLYSS, NEMLUVIO, SKYRIZI, Zoryve, DUPIXENT.
Industry payments across IA — which companies pay providers there.
